<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="125987">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01809574</url>
  </required_header>
  <id_info>
    <org_study_id>225-12-MMC</org_study_id>
    <nct_id>NCT01809574</nct_id>
  </id_info>
  <brief_title>The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease</brief_title>
  <official_title>The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients
      would lead to a more accurate diagnosis and consequently alterations in treatment regimens
      that may lead to improved outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>The number of patients with collagen related pulmonary fibrosis that are diagnosed by Rheumatologists compared to Pulmonologists.</measure>
    <time_frame>two years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <condition>Connective Tissue Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        60 patients that will refer to the pulmonary outpatient or inpatients department for
        evaluation due to ILD will be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 18 years old

          -  ILD according to ATS/ERS guidelines

          -  Signed inform consent

        Exclusion Criteria:

          -  Previous lung surgery

          -  Other significant systemic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Shitrit, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Pulmonary departmant, Meir Medical Center.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Shitrit, Dr.</last_name>
    <phone>097471556</phone>
    <email>davids3@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <zip>972</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Shitrit, Dr</last_name>
      <phone>09-7471556</phone>
      <email>davids3@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 6, 2013</lastchanged_date>
  <firstreceived_date>March 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interstitial lung disease</keyword>
  <keyword>Idiopathic pulmonary fibrosis</keyword>
  <keyword>Connective tissue disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Connective Tissue Diseases</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
